According to the United Nations, worldwide nearly 1.3 million lives are lost in traffic accidents each year and this number could rise to nearly 1.9 million in the next 10 years. Furthermore, estimates show that nearly 90 percent of all crashes are caused by driver error, making advanced safety systems an important focus for automakers and governing agencies. Bosch offers active and passive safety technologies, as well as driver assistance functions that can help reduce the number of accidents and save lives.
To view Multimedia News Release, go to http://www.multivu.com/mnr/48705-bosch-helps-drivers-avoid-crashes-reduce-injuries
The Corporate Executive Board (CEB) (NYSE: EXBD), a leading research and advisory services company, today announced the publication of Executive Guidance 2011, the company’s year-end analysis of industry trends and corporate best practices designed to inform and support business planning. This year’s Executive Guidance focuses on “Intelligent Growth”—a long-term pattern of above-industry performance in both revenue growth and efficiency—and highlights four key management principles that are critical to achieving it. While most companies aspire to create this balance, currently less than 10 percent of global organizations are considered Intelligent Growth companies.
To view Mulimedia News Release, go to http://multivu.prnewswire.com/mnr/executiveboard/45060/
Join O2 Rugby Reunion this summer and make the comeback to end all comebacks. It's time to put the old team back together and get back out there. Each event has food, drink, competitions, prizes and England players present. Go to http://bit.ly/O2Rugby_YouTube for details.
I declare WAR on LOVE
http://www.desteni.co.za
http://www.desteni-money.net
http://www.youtube.com/mattifreeman1
http://www.myspace.com/matterfreeman
Equal Money for All from Birth
Dignified Life Campaign
End the fight for survival with Equal Money for All
ConAgra Foods® (NYSE: CAG) and Feeding America®, the nation’s leading domestic hunger-relief organization, will premiere “Child Hunger Ends Here: A Special Report” on select NBC stations across the nation on March 19. The 30-minute special, hosted by Al Roker with Natalie Morales, gives viewers a better understanding about the negative effects of hunger on children and how they can help end child hunger.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/conagra/48986/
The Medium Extended Air Defense System (MEADS) successfully completed its first flight test today at White Sands Missile Range, N.M.
The PAC-3 Missile Segment Enhancement (MSE) MEADS Certified Missile Round was employed during the test along with the MEADS lightweight launcher and battle manager.
The test demonstrated an unprecedented over-the-shoulder launch of the MSE missile against a simulated target attacking from behind. It required a unique sideways maneuver, demonstrating a 360-degree capability. The missile executed a planned self-destruct sequence at the end of the mission after successfully engaging the simulated threat.
To view Multimedia News Release, go to http://www.multivu.com/mnr/53248-meads-conducts-successful-first-flight-test-white-sands-missile-range
The Coalition to End Childhood Lead Poisoning, U.S. Environmental Protection Agency (EPA), and U.S. Department of Housing and Urban Development (HUD) are joining the Ad Council today to unveil a new series of national public service advertisements (PSAs) to raise awareness about childhood lead poisoning. The PSAs are being distributed today to kick off National Lead Poisoning Prevention Week (NLPPW). Additionally, the campaign’s social media presence through Facebook and Twitter will reinforce to parents, caregivers and pregnant women that if their home was built before 1978, they should have their child tested for lead poisoning.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52687-ad-council-lead-poisoning-prevention-week-english-psa
Nobody likes to sell themselves short in life and end up a data entry clerk. If you say your dream is to be an architect you don\'t want to end up tapping a keyboard while you cry out from the sheer mind-numbing boredom of it all.
Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s antibacterial drug DIFICID™ (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age and older. CDAD is a significant medical problem in hospitals and long-term care facilities, and is beginning to emerge in the community among people previously at low risk for the disease. In the largest Phase 3 clinical studies ever conducted in CDAD, DIFICID had clinical response rates at the end of treatment that were non-inferior to oral vancomycin. DIFICID was superior to vancomycin in sustaining clinical response through 25 days beyond the end of treatment. DIFICID is the only FDA-approved antibacterial drug proven to be superior to vancomycin in sustained clinical response for CDAD.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/optimerpharma/50177/
Everyday they pass me by,
I can see it in their eyes.
Empty people filled with care,
Headed who knows where?
On they go through private pain,
Living fear to fear.
Laughter hides their silent cries,
Only Jesus hears.
People need the Lord, people need the Lord.
At the end of broken dreams, He
Bill Gates, co-chair of the Bill & Melinda Gates Foundation, called on government leaders to increase their investments in vaccines and to hold themselves accountable for extending the benefits of vaccines to every child.
In a keynote address at the 64th World Health Assembly, an annual gathering of health ministers and global health leaders, Gates laid out his vision for the impact that broadening access to vaccines can have on the world. “Strong immunization systems will put an end to polio and help us reach all children with five to six new vaccines,” Gates said. “We can save four million lives by 2015, and 10 million lives by 2020.”
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/gatesfoundation/49363/
